¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Naphazoline/ Zinc Sulfate Drops"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ferric sulfate
    öȲ»ê¿°
  • heparan sulfate
    ÇìÆÄ¶õȲ»ê¿°
  • hydrazine sulfate
    È÷µå¶óÁøÈ²»ê¿°
  • keratan sulfate
    ÄɶóźȲ»ê¿°
  • lead sulfate
    ³³È²»ê¿°
  • magnesium sulfate
    ¸¶±×³×½·È²»ê¿°
  • protamine sulfate
    ÇÁ·ÎŸ¹ÎȲ»ê¿°
  • sulfate
    Ȳ»ê¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hydrazine sulfate
    È÷µå¶óÁøÈ²»ê¿°
  • lead sulfate
    Ȳ»ê³³
  • magnesium sulfate
    Ȳ»ê¸¶±×³×½·
  • sulfate
    Ȳ»ê¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dermatan sulfate
    ´õ¸¶Åº Ȳ»ê¿°(¡­üÜß«ç¤)
  • dexedrine sulfate
    Ȳ»ê(üÜß«)µ¦¼¼µå¸°.
  • ephedrine sulfate
    Ȳ»ê(üÜß«)¿¡Æäµå¸°.
  • etheral sulfate
    ¿¡Å׸£È²»ê(¡­üÜß«).
  • ferric sulfate
    ¿°È­Ã¶
  • ferrous sulfate dosimetry
    Ȳȭö¼±·®ÃøÁ¤
  • heparan sulfate
    Ȳ»êÇìÆÄ¶õ
  • heparan sulfate
    Ȳ»ê ÇìÆÄ¶õ, Ȳ»ê heparan
  • hydrazine sulfate
    Ȳ»ê(üÜß«)È÷µå¶óÁø.
  • hyoscyamine sulfate
    Ȳ»êÈ÷¿À½º½Ã¾Æ¹Î.
  • lead sulfate
    Ȳ»ê(Ì·Ë×)³³.
  • magnesium sulfate
    Ȳ»ê(üÜß«)¸¶±×³×½·.
  • magnesium sulfate
    Ȳ»ê¸¶±×³×½·
  • protamine sulfate
  • serial dilution protamine sulfate test
    °è´ÜÈñ¼® ÇÁ·ÎŸ¹Î¼³ÆäÀÌÆ®½ÃÇè
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sulfate assimilation
    Ȳ»êµ¿È­ÀÛ¿ë(üÜß«ÔÒûùíÂéÄ)
  • sulfate dissimilation
    Ȳ»êÀÌÈ­ÀÛ¿ë(üÜß«ì¶ûùíÂéÄ)
  • sulfate reduction
    Ȳ»êȯ¿ø(üÜß«ü½êª)
  • sulfate respiration
    Ȳ»êÈ£Èí(üÜß«û¼ýå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ZPP Zinc Proto-Porphyrin
AEZ acrodermatitis enteropathica, zinc deficient
AZGP zinc-alpha-2-glycoprotein
Czn zinc clearance
IPZ insulin protamine zinc
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PLZF Promyelocytic leukemia zinc finger
SZL Serum zinc level
Zn2+ Zinc
ZIO Zinc Iodide Osmium
ZAC Zinc acexamate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrazine sulfate
    Ȳ»ê È÷µå¶óÁø
  • liquid ferrous sulfate
    ¾×ü Ȳ»ê Á¦1ö
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium sulfate
    Ȳ»ê ³ªÆ®·ý
    ¹Ù·ý Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦ ¼³»ç ¾àÀ¸·Î »ç¿ëÇϸç, °¨¿°µÈ »óó¿¡ ´ëÇÑ ÃÖ¸²ÇÁ ¾àÀ¸·Î¼­ ±¹¼ÒÀûÀ¸·Î »ç¿ëÇϱ⵵ ÇÑ´Ù.
  • sodium tetradecyl sulfate
    Åׯ®¶óµ¥½ÇȲ»ê³ªÆ®·ý
    °æÈ­¼ºÀ» °®´Â À½À̿ °è¸éȰ¼ºÁ¦, ¹é»öÀÇ ¹Ð¶ø¼º °íü. ½ÀÀ±Á¦·Î¼­ ¾²À̸ç, Á¤¸Æ·ù¿Í Ä¡ÁúÀÇ Ä¡·á·Îµµ »ç¿ëÇÑ´Ù.
  • dietary zinc
    ½ÄÀ̼º ¾Æ¿¬
  • insulin zinc suspension
    Àν¶¸° ¾Æ¿¬ Çöʾ×
  • protamin zinc insulin
    ÇÁ·ÎŸ¹Î ¾Æ¿¬
  • zinc
    ¾Æ¿¬
    û¹é»öÀÇ ±Ý¼Ó ¿ø¼Ò·Î ¸¹Àº ¾Æ¿°¿¬ÀÌ ÀǾàǰÀ¸·Î »ç¿ëµÈ´Ù. ¿ø¼Ò±âÈ£ Zn, ¿øÀÚ¹øÈ£ 30 ¿øÀÚ·® 65.37ÀÌ´Ù. ¾Æ¿¬Àº Èí¼öµÇ¸é µ¶¼ºÀ» °®±â ¶§¹®¿¡ ¾Æ¿¬ÀÇ ¸¸¼º Áßµ¶°ú ºñ½ÁÇÏ°Ô µÈ´Ù.
  • zinc carbonate
    ¼®Åº»ê ¾Æ¿¬
  • zinc colic
    ¾Æ¿¬ »êÅë
  • zinc dust
    ¾Æ¿¬ Áø
  • zinc insulin crystals
    ¾Æ¿¬ Àν¶¸° °áÁ¤
  • zinc oxide
    »êÈ­ ¾Æ¿¬
    ¾ÆÁÖ ÀÛÀº ¹«Ãë, ¹«Á¤ÇüÀÇ ¹é»ö ¶Ç´Â Ȳ¹é»öÀÇ ºÐ¸», ZnO, ±¹¼ÒÀûÀ¸·Î ¼ö·ÅÁ¦ ¶Ç´Â º¸È£Á¦·Î »ç¿ëµÈ´Ù.
  • zinc oxide eugenol impression paste
    »êÈ­ ¾Æ¿¬ À¯Áö³î ÀλóÁ¦
    »êÈ­ ¾Æ¿¬°ú À¯Áö³îÀÇ ¹ÝÀÀÀ» ÀÌ¿ëÇÑ ÀλóÁ¦·Î, °æÈ­Çϸé Ã뼺À» º¸À̹ǷΠ¿À·ÎÁö ¹«Ä¡¾ÇÀÇ Àλó 䵿¿¡ »ç¿ëÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
modified zinc oxide-eugenol cement Dental cement obtained by mixing zinc oxide and eugenol with one or more additives.
(05 Mar 2000)
crystalline insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
prompt insulin zinc suspension Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection.
Synonym: amorphous insulin zinc suspension, semilente insulin.
(05 Mar 2000)
protamine zinc insulin Insulin modified by the addition of protamine and zinc chloride; it contains 40 or 80 units per ml.
(05 Mar 2000)
deficiency dermatitis and diarrhoea, zinc A genetic disease called acrodermatitis enteropathica is characterised by the simultaneous occurrence of skin inflammation (dermatitis) and diarrhoea. The skin on the cheeks, elbows and knees and tissue about the mouth and anus are inflammed. There is also balding of the scalp, eyebrows and lashes, delayed wound healing and recurrent bacterial and fungal infections due to immune deficiency. The key laboratory finding is an abnormally low blood zinc level reflecting impaired zinc uptake. Oral treatment with zinc is curative.
(12 Dec 1998)
deficiency, zinc Deficiency of zinc is associated with short stature, anaemia, increased pigmentation of skin (hyperpigmentation), enlarged liver and spleen (hepatosplenomegaly), impaired gonadal function (hypogonadism), impaired wound healing, and immune deficiency. (For a genetic disorder that impairs zinc uptake, please see Acrodermatitis enteropathica). According to the National Academy of Sciences, the Recommended Dietary Allowances of zinc are 12 milligrams per day for women and 10 milligrams per day for men. Food sources of zinc include meat including liver, eggs, seafood, nuts and cereal.
(12 Dec 1998)
insulin, protamine zinc <chemical> A long-acting insulin with an approximate time of onset of 7 hours and duration of action 36 hours, consisting of bovine or pork insulin reacted with zinc chloride and protamine to form a protein complex from which insulin is slowly released.
Pharmacological action: hypoglycaemic agents.
Chemical name: Insulin protamine zinc
(12 Dec 1998)
insulin zinc suspension A sterile buffered suspension with zinc chloride, containing 40 or 80 units per ml; the solid phase of the suspension consists of a mixture of 7 parts of crystalline insulin and 3 parts of amorphous insulin.
Synonym: lente insulin.
(05 Mar 2000)
extended insulin zinc suspension A long-acting insulin suspension, obtained from beef, with an approximate time of onset of 7 hours and a duration of action of 36 hours.
Synonym: crystalline insulin zinc suspension.
(05 Mar 2000)
zinc <chemistry, element> An essential trace element being an essential component of the active site of a variety of enzymes.
Zinc has a high affinity for the side chains of cysteine and histidine. Zinc is present in tissues at levels of 0.1mM, but intracellular levels must be much lower.
Abbreviation: Zn
(18 Nov 1997)
zinc-65 A radioactive zinc isotope that decays mainly by K-capture with a half-life of 243.8 days; used as a tracer in studies of zinc metabolism.
(05 Mar 2000)
zinc acetate <chemical> A salt produced by the reaction of zinc oxide with acetic acid. It is used as a pharmaceutic necessity for zinc-eugenol cement and also as an astringent, styptic, and formerly as an emetic.
Pharmacological action: astringents, pharmaceutic aid.
(12 Dec 1998)
zinc arsenate <chemical> A toxic compound of zinc and arsenic which is used as an insecticide and to preserve timber from decay.
(11 May 1997)
zinc caprylate A topical antifungal compound.
(05 Mar 2000)
zinc chloride ZnCl2;formerly used as a caustic for the removal of cutaneous cancers, nevi, etc., and in weak solution in the treatment of gonorrhoea and conjunctivitis.
Synonym: butter of zinc.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sulfate
    Ȳ»ê°ú È­ÇÕ½ÃŰ´Ù(À¸·Î ó¸®ÇÏ´Ù);(ÃàÀüÁöÀÇ ¿¬ÆÇ¿¡)Ȳ»ê¿° È­ÇÕ¹°À» ħÀü½ÃŰ´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á